MV Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
15,592
-214
-1% -$17.3K 0.11% 89
2026
Q1
$1.37M Sell
15,806
-1,680
-10% -$161K 0.13% 87
2025
Q4
$1.68M Buy
17,486
+288
+2% +$28K 0.16% 81
2025
Q3
$1.64M Sell
17,198
-331
-2% -$30.4K 0.16% 84
2025
Q2
$1.53M Sell
17,529
-1,254
-7% -$106K 0.16% 84
2025
Q1
$1.69M Sell
18,783
-4,625
-20% -$414K 0.18% 80
2024
Q4
$1.87M Sell
23,408
-11
-0% -$952 0.2% 78
2024
Q3
$2.11M Sell
23,419
-1,140
-5% -$95.9K 0.22% 77
2024
Q2
$1.93M Buy
24,559
+544
+2% +$44.6K 0.22% 74
2024
Q1
$2.09M Buy
24,015
+15,830
+193% +$1.35M 0.24% 74
2023
Q4
$674K Sell
8,185
-11,738
-59% -$895K 0.09% 102
2023
Q3
$1.56M Buy
19,923
+529
+3% +$44.3K 0.21% 71
2023
Q2
$1.71M Buy
19,394
+3,008
+18% +$259K 0.23% 63
2023
Q1
$1.32M Buy
16,386
+354
+2% +$28.9K 0.19% 71
2022
Q4
$1.25M Buy
16,032
+272
+2% +$22K 0.19% 68
2022
Q3
$1.27M Buy
15,760
+3,284
+26% +$295K 0.22% 64
2022
Q2
$1.12M Sell
12,476
-649
-5% -$65.8K 0.19% 72
2022
Q1
$1.46M Buy
13,125
+789
+6% +$83.4K 0.22% 73
2021
Q4
$1.28M Buy
12,336
+7
+0.1% +$811 0.19% 72
2021
Q3
$1.54M Buy
12,329
+837
+7% +$108K 0.26% 68
2021
Q2
$1.43M Buy
11,492
+640
+6% +$80.4K 0.24% 72
2021
Q1
$1.28M Buy
10,852
+1,691
+18% +$198K 0.23% 69
2020
Q4
$1.07M Buy
9,161
+1,076
+13% +$118K 0.2% 65
2020
Q3
$840K Buy
8,085
+2,082
+35% +$209K 0.17% 62
2020
Q2
$550K Buy
6,003
+1,487
+33% +$143K 0.13% 70
2020
Q1
$407K Buy
4,516
+567
+14% +$60.3K 0.11% 69
2019
Q4
$448K Buy
3,949
+399
+11% +$43.8K 0.1% 81
2019
Q3
$386K Buy
3,550
+229
+7% +$23.9K 0.09% 81
2019
Q2
$323K Buy
3,321
+457
+16% +$41.7K 0.07% 85
2019
Q1
$261K Buy
2,864
+284
+11% +$25.4K 0.06% 92
2018
Q4
$235K Buy
2,580
+230
+10% +$21.5K 0.07% 87
2018
Q3
$231K Sell
2,350
-36
-2% -$3.33K 0.06% 91
2018
Q2
$204K Buy
2,386
+7
+0.3% +$585 0.05% 94
2018
Q1
$191K Sell
2,379
-63
-3% -$5.2K 0.05% 97
2017
Q4
$197K Sell
2,442
-20
-0.8% -$1.6K 0.05% 100
2017
Q3
$191K Sell
2,462
-268
-10% -$22.3K 0.05% 95
2017
Q2
$242K Buy
2,730
+79
+3% +$6.66K 0.07% 82
2017
Q1
$214K Sell
2,651
-3
-0.1% -$234 0.07% 89
2016
Q4
$189K Sell
2,654
-278
-9% -$21.8K 0.07% 92
2016
Q3
$253K Sell
2,932
-452
-13% -$39.4K 0.09% 71
2016
Q2
$294K Buy
3,384
+180
+6% +$14.6K 0.11% 72
2016
Q1
$240K Buy
3,204
+716
+29% +$53.9K 0.1% 77
2015
Q4
$191K Buy
2,488
+816
+49% +$61.4K 0.08% 95
2015
Q3
$112K Buy
1,672
+495
+42% +$36.5K 0.05% 109
2015
Q2
$87K Buy
1,177
+251
+27% +$19.2K 0.04% 134
2015
Q1
$72K Hold
926
0.03% 143
2014
Q4
$67K Buy
+926
New +$64.3K 0.03% 144

Other funds holding MDT

MV Capital Management's MDT Position: Q2 2026 in Review

MV Capital Management reduced its Medtronic (MDT) stake by 1.4% in Q2 2026, selling an estimated $17.3K and leaving 15,592 shares worth $1.22M. The position accounts for 0.11% of the portfolio, ranked #89.

MV Capital Management first reported a position in MDT in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.11M in Q3 2024. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • MV Capital Management held 15,592 shares of Medtronic worth $1.22M as of Q2 2026.
  • MV Capital Management sold 214 Medtronic shares in Q2 2026, an estimated $17.3K.
  • Medtronic made up 0.11% of MV Capital Management's portfolio in Q2 2026, its #89 holding.
  • MV Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 47 quarters since.
  • MV Capital Management's Medtronic position peaked at $2.11M in Q3 2024.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.